Parker Institute for Cancer Immunotherapy coordinates cancer research efforts between scientists, clinicians and partners in the industry.
Business Model:
Revenue: $2.4M
Employees: 11-50
Address: 1 Letterman Drive
City: San Francisco
State: CA
Zip: 94129
Country: US
The Parker Institute for Cancer Immunotherapy brings together the best scientists, clinicians and industry partners to build a smarter and more coordinated cancer immunotherapy research effort to save lives.
Contact Phone:
+14155041544
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2022 | Senti Biosciences | Post-IPO Equity | 0 |
3/2022 | Affini-T Therapeutics | Venture Round | 0 |
1/2018 | Tmunity Therapeutics | Series A | 0 |
10/2019 | ArsenalBio | Series A | 0 |
9/2022 | ArsenalBio | Series B | 0 |
1/2023 | Akamis Bio | Debt Financing | 0 |
9/2017 | ImaginAb | Venture Round | 0 |
4/2018 | Tmunity Therapeutics | Series A | 0 |
12/2015 | Tmunity Therapeutics | Seed Round | 0 |
6/2022 | Senti Biosciences | Post-IPO Equity | 0 |
3/2022 | Affini-T Therapeutics | Venture Round | 0 |
10/2019 | ArsenalBio | Series A | 0 |
4/2018 | Tmunity Therapeutics | Series A | 0 |
1/2018 | Tmunity Therapeutics | Series A | 0 |
9/2017 | ImaginAb | Venture Round | 0 |
12/2015 | Tmunity Therapeutics | Seed Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|